Resveratrol enhances HBV replication through activating Sirt1-PGC-1α-PPARα pathway

The population of hepatitis B combined with a number of metabolic disorders is increasing significantly. Resveratrol (RSV) has been used as a preclinical drug for the treatment of the metabolic disorders. However, the impact of RSV on HBV replication remains unknown. In this study, the HBV-expressin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Shi, Yixian, Li, Yongjun, Huang, Chenjie, Ying, Lixiong, Xue, Jihua, Wu, Haicong, Chen, Zhi, Yang, Zhenggang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4838842/
https://ncbi.nlm.nih.gov/pubmed/27098390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep24744
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia